Showing 4,181 - 4,200 results of 9,864 for search '"drug"', query time: 0.10s Refine Results
  1. 4181

    Recurrent Respiratory Papillomatosis Causing Chronic Stridor and Delayed Speech in an 18-Month-Old Boy by Adel Alharbi, Derek Drummond, Alfredo Pinto, Valerie Kirk

    Published 2006-01-01
    “…CO2 laser evaporation of papillomas and adjuvant drug therapy using lymphoblastoid interferon-alpha are the most common treatments. …”
    Get full text
    Article
  2. 4182

    The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis by Ye. A. Poluektova, S. Yu. Kuchumova, A. A. Sheptulin, V. T. Ivashkin

    Published 2013-03-01
    “…The treatment of the patients is based on the IBS clinical subtypes and include the antidiarrheal drugs, laxatives and spasmolytics. The good results were obtained during the administration of the combined drug Meteospasmyl (the combination of alverine citrate and simeticone). …”
    Get full text
    Article
  3. 4183

    Milk-derived extracellular vesicles and gut health by Barathan Muttiah, Jia Xian Law

    Published 2025-01-01
    “…These findings underscore the promising role of milk-derived EVs in advancing GI health and therapeutics, paving the way for innovative approaches in oral drug delivery and targeted treatments for GI disorders.…”
    Get full text
    Article
  4. 4184

    Single Photon Emission Tomography Imaging in Parkinsonian Disorders: A Review by Paul D. Acton, P. David Mozley

    Published 2000-01-01
    “…Imaging is now being utilised to elucidate the genetic contribution to Parkinson’s disease, and in longitudinal studies to assess the efficacy and mode of action of neuroprotective drug and surgical treatments. This review summarises recent applications of SPECT imaging in the study of parkinsonian disorders, with particular reference to the increasing role it is playing in the understanding, diagnosis and management of these diseases.…”
    Get full text
    Article
  5. 4185
  6. 4186

    Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia by Amer Aljundi, Alaa Rahhal, Wafer Dabdoob

    Published 2020-01-01
    “…We describe a case of a 62-year-old female patient admitted with acute ST-elevation myocardial infarction (STEMI) treated by primary coronary intervention (primary PCI) with a drug-eluting stent placement. She developed profound thrombocytopenia within 8 hours of first administration of eptifibatide and subsequent acute stent thrombosis next day. …”
    Get full text
    Article
  7. 4187

    Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights by Xinyu Li, Haiying Zhao

    Published 2025-02-01
    “…Moreover, substances released by secretory autophagy convey biological signals to the TME, inducing immune dysregulation and contributing to drug resistance. Therefore, elucidating the mechanisms underlying secretory autophagy is essential for improving clinical treatments. …”
    Get full text
    Article
  8. 4188

    Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment by Walter Belda, Luiz Felipe Domingues Passero, Ana Thereza Stradioto Casolato

    Published 2021-01-01
    “…The classic treatment of sporotrichosis is performed with itraconazole or potassium iodide; second-line medications, such as amphotericin B and terbinafine, can alternatively be used in cases of first-line drug failure. In the present study, a patient with lymphocutaneous sporotrichosis in the right upper limb exhibited intolerance to itraconazole and potassium iodide, additionally during the period of use; these drugs did not control skin lesions. …”
    Get full text
    Article
  9. 4189
  10. 4190

    Stratégies argumentatives dans les discours politiques américains sur la législation des substances psychoactives : quel emploi du pathos à l’ère de la post-vérité ? by Sarah Bourse

    Published 2020-12-01
    “…The present study focuses on a corpus of political speeches about drug reform. The “War on Drugs” is a significant matter of public health that can be tackled from a medical or a criminal point of view. …”
    Get full text
    Article
  11. 4191

    Influence of novel oral anticoagulants on anticoagulation care management by Janzic Andrej, Kos Mitja

    Published 2017-09-01
    “…Obtained information was further explored through the analysis of nationwide data of drug prescriptions and realization of health care services. …”
    Get full text
    Article
  12. 4192

    Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints. by Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz König, EU-PEARL NASH Investigators

    Published 2023-01-01
    “…Platform trials provide great benefits for sponsors and trial participants in terms of accelerating drug development programs. In this article, we describe some of the activities of the EU-PEARL consortium (EU Patient-cEntric clinicAl tRial pLatforms) regarding the use of platform trials in NASH, in particular the proposed trial design, decision rules and simulation results. …”
    Get full text
    Article
  13. 4193

    Restenosis and Therapy by Laszlo Denes, Laszlo Entz, Veronika Jancsik

    Published 2012-01-01
    “…Gene therapy and therapeutic angiogenesis is proposed for therapy in restenosis. We suggest a drug candidate (iroxanadine), which ensures a noninvasive treatment by reverse regulation of the highly proliferating VSMCs and the disturbed function of ECs.…”
    Get full text
    Article
  14. 4194

    One-Pot Synthesis of Novel Furochromone and Oxazocine Derivatives as Promising Antitumor Agents with Their Molecular Docking Studies by Rita M. Borik

    Published 2020-01-01
    “…The antitumor results suggested that furochromone derivatives 5a–h have activity against MCF7 in comparison with doxorubicin as the standard drug. Furthermore, the molecular docking studies of these novel derivatives of furochromone and oxazocine showed good agreement with the biological results when their binding pattern and affinity towards the active site of EGFR was investigate.…”
    Get full text
    Article
  15. 4195

    Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature by Carolina Afonso, Adriana Roque, Cátia Almeida, Maria Beatriz Pimentão, Maria José Julião, Rodolfo Silva, Catarina Geraldes, Marília Gomes

    Published 2022-01-01
    “…Outside the posttransplant setting, methotrexate (MTX), a drug commonly used for the treatment of autoimmune diseases, is an immunosuppressive agent frequently reported to be associated with LPD. …”
    Get full text
    Article
  16. 4196

    A Turn-On Fluorescent Sensor for Glutathione Based on Bovine Serum Albumin-Stabilized Gold Nanoclusters by Yan Qiu, Jianlin Huang, Li Jia

    Published 2018-01-01
    “…The fluorescence sensor successfully detected glutathione in commercial drug products.…”
    Get full text
    Article
  17. 4197

    Unique Findings and Novel Treatment Strategy of a Giant Coronary Artery Aneurysm Associated with a Significant Pericardial Effusion by Osayi Lawani, Rick Ganim

    Published 2020-01-01
    “…We will also present its unusual repair using a long drug-eluting stent as a scaffold to overlap covered coronary stents used to help exclude the aneurysm.…”
    Get full text
    Article
  18. 4198

    Conquering myositis, beyond remission by Amber O'Connor, T G Sundaram

    Published 2020-01-01
    “…Akin to a stowed sailboat, limiting management of chronic illnesses such as idiopathic inflammatory myopathies (IIM) to diagnosis, investigations, and drug prescriptions, is like leaving the seas unchartered. …”
    Get full text
    Article
  19. 4199

    Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application by Romilly E. Hodges, Deanna M. Minich

    Published 2015-01-01
    “…Clinical applications to alter detoxification pathway activity and improve patient outcomes are considered, drawing on the growing understanding of the relationship between detoxification functions and different disease states, genetic polymorphisms, and drug-nutrient interactions. Some caution is recommended, however, due to the limitations of current research as well as indications that many nutrients exert biphasic, dose-dependent effects and that genetic polymorphisms may alter outcomes. …”
    Get full text
    Article
  20. 4200